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Abstract
Genetic code expansion is a powerful technique for site-specific incorporation of an unnatural amino acid into a protein of 
interest. This technique relies on an orthogonal aminoacyl-tRNA synthetase/tRNA pair and has enabled incorporation of over 
100 different unnatural amino acids into ribosomally synthesized proteins in cells. Pyrrolysyl-tRNA synthetase (PylRS) and 
its cognate tRNA from Methanosarcina species are arguably the most widely used orthogonal pair. Here, we investigated 
whether beneficial effect in unnatural amino acid incorporation caused by N-terminal mutations in PylRS of one species is 
transferable to PylRS of another species. It was shown that conserved mutations on the N-terminal domain of MmPylRS 
improved the unnatural amino acid incorporation efficiency up to five folds. As MbPylRS shares high sequence identity to 
MmPylRS, and the two homologs are often used interchangeably, we examined incorporation of five unnatural amino acids 
by four MbPylRS variants at two temperatures. Our results indicate that the beneficial N-terminal mutations in MmPylRS 
did not improve unnatural amino acid incorporation efficiency by MbPylRS. Knowledge from this work contributes to our 
understanding of PylRS homologs which are needed to improve the technique of genetic code expansion in the future.
Keywords Genetic code expansion · Unnatural amino acid · Non-canonical amino acid · Pyrrolysyl-tRNA synthetase 
(PylRS)
Abbreviations
AcK  Acetyl lysine
BocK  Nε-Boc-lysine
IPTG  Isopropyl β-d-1-thiogalactopyranoside
MbPylRS  Methanosarcina barkeri Pyrrolysyl-tRNA 
synthetase
MmPylRS  Methanosarcina mazei Pyrrolysyl-tRNA 
synthetase
PCC  Photocaged cysteine
PylRS  Pyrrolysyl-tRNA synthetase
PrK  Propionyl lysine
TAcK  Thioacetyl lysine
Introduction
The ability to genetically introduce an unnatural (i.e., non-
canonical) amino acid with unique chemical and physi-
cal properties into a defined position of a target protein 
has provided a new avenue to investigate protein function 
(Brown et al. 2018; Chin 2017; Nodling et al. 2019; Young 
and Schultz 2018). This approach known as genetic code 
expansion relies on an orthogonal aminoacyl-tRNA syn-
thetase/tRNA pair to direct the site-specific incorporation 
of an unnatural amino acid in response to a blank codon. 
The amber stop codon (UAG) is usually chosen as the blank 
codon because it does not encode a canonical amino acid 
and is the least used codon in most organisms (Athey et al. 
2017). Here, it is critical that the orthogonal synthetase only 
acylates the orthogonal tRNA with the designated unnatural 
amino acid, and neither the orthogonal tRNA nor the unnat-
ural amino acid is a substrate of endogenous synthetases. 
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The pyrrolysyl-tRNA synthetase (PylRS) from archaea 
Methanosarcina barkeri (MbPylRS) or Methanosarcina 
mazei (MmPylRS) and its cognate tRNA (Pyl tRNA) are 
arguably the most widely used orthogonal pair for genetic 
code expansion in bacteria and eukaryotes (Brown et al. 
2018; Chin 2017; Nodling et al. 2019). The two organisms 
have identical sequences for Pyl tRNA (Srinivasan et al. 
2002; Suzuki et al. 2017) that naturally decodes the amber 
codon. MbPylRS and MmPylRS also have high sequence 
identity (74%). While wild-type MbPylRS and MmPylRS 
can recognize some unnatural amino acids, protein engineer-
ing of these homologous enzymes has enabled incorporation 
of over 100 different unnatural amino acids with diverse 
chemical and physical properties (Brown et al. 2018; Chin 
2017; Nodling et al. 2019).
Despite these advances, the use of the amber codon to 
encode an unnatural amino acid is not without limitation. 
The amber codon can still be recognized by the release fac-
tor, causing translation termination and production of the 
truncated protein product. To circumvent this problem, dif-
ferent approaches have been explored. In one instance, an 
orthogonal ribosome has been engineered that has much 
lower affinity to the release factor (An and Chin 2009; 
Barrett and Chin 2010; Neumann et  al. 2010). In fact, 
the orthogonal ribosome recognizes an alternative Kozak 
sequence, the amber codon on the reporter gene can be pref-
erentially decoded as the unnatural amino acid, minimizing 
unwanted premature termination. In other approaches, the 
elongation factor can be engineered or the release factor can 
be removed to increase the amber suppression efficiency 
(Gan et al. 2017; Johnson et al. 2011; Schmied et al. 2014). 
Nevertheless, the general applicability of these approaches 
(An and Chin 2009; Barrett and Chin 2010; Gan et al. 2017; 
Johnson et al. 2011; Neumann et al. 2010; Schmied et al. 
2014) is limited because the translational systems in prokar-
yotic cells and eukaryotic cells are vastly different and not 
readily interchangeable. Hence, an alternative approach that 
would function in both E. coli and mammalian cells is highly 
desirable, and this may be achieved by directly engineering 
the non-substrate binding part of the orthogonal synthetase 
to improve its catalytic activity (Owens et al. 2017; Sharma 
et al. 2018).
To improve unnatural amino acid incorporation, both 
MbPylRS and MmPylRS need to be thoroughly investigated. 
These homologs contain two domains, the C-terminal and 
N-terminal domains. The C-terminal domain possesses the 
catalytic site and binds to ATP and the unnatural amino 
acid. On the other hand, the N-terminal domain is impor-
tant for the enzymatic activity in cells through interaction 
with the tRNA though is not directly involved in unnatu-
ral amino acid recognition (Suzuki et al. 2017). Often dis-
covered through rational design, directed evolution or a 
combination of both, mutations in the C-terminal domain 
can expand the substrate scope, enabling incorporation of 
structurally diverse unnatural amino acids. On the other 
hand, though not directly involved in catalysis, mutations 
in the N-terminal domain have been demonstrated to affect 
the efficiency of unnatural amino acid incorporation in 
variants of MmPylRS, MbPylRS and their chimera (Bryson 
et al. 2017; Owens et al. 2017; Sharma et al. 2018). In a 
study to increase the incorporation of crotonyl lysine by a 
MbPylRS variant, six mutations (V8E, T13I, I36V, H45L, 
S121R, I355T) predominantly localized in the N-terminal 
domain were identified through random mutagenesis, and 
about threefold increase in crotonyl lysine incorporation 
was observed (Owens et al. 2017). When transferring these 
six mutations to another MbPylRS variant for incorporating 
Nε-[(2-propynyloxy)carbonyl]-L-lysine, a similar beneficial 
effect was observed. Another study found that R19H/H29R/
T122S mutations in the N-terminal domain improved the 
capability of three MmPylRS variants for unnatural amino 
acid incorporation, and up to sixfold increase in the yields 
of recombinant proteins containing an unnatural amino acid 
was observed (Sharma et al. 2018). These studies indicate 
that mutations in the N-terminal domain can affect the incor-
poration efficiency. However, while C-terminal mutations 
are transferable between MbPylRS and MmPylRS to rec-
ognize specific unnatural amino acids (Brown et al. 2018; 
Chin 2017; Nodling et al. 2019), it remains elusive if the 
N-terminal mutations are also transferable between these 
two homologs.
Provided that MbPylRS and MmPylRS are often used 
interchangeably for unnatural amino acid incorporation 
(Brown et al. 2018; Chin 2017; Nodling et al. 2019), ben-
eficial mutations found in the N-terminal domain of one 
homolog are likely to be transferable to that of the other. 
As the MmPylRS variant R19H/H29R/T122S was reported 
to have improved activity, we propose that these mutations 
may have beneficial effect for the incorporation of unnatural 
amino acids by MbPylRS. As the corresponding position 
of MmPylRS T122 in MbPylRS is already a serine residue 
(Fig. 1), whereas R19 and H29 are conserved in the two 
Fig. 1  Partial sequence alignment of MmPylRS and MbPylRS. Amino acid sequence of MmPylRS (UniProt: Q8PWY1) and MbPylRS (UniProt: 
Q6WRH6) is aligned using ExPASy (https ://web.expas y.org/sim/)
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homologs. Thus, we set out to probe the effect of R19H/
H29R mutations in unnatural amino acid incorporation by 
MbPylRS variants.
Here, we examined four MbPylRS variants (i.e., wild-
type, AcKRS, PrKRS, PCCRS) for incorporating unnatu-
ral amino acids (Fig. 2) under two different temperatures 
(37 °C or 25 °C). Five different unnatural amino acids Nε-
Boc-lysine (BocK), acetyl lysine (AcK), thioacetyl lysine 
(TAcK), propionyl lysine (PrK) and photocaged cysteine 
(PCC) were used here for our examination. BocK can be 
incorporated by wild-type MbPylRS and is often used as a 
model unnatural amino acid in proof-of-principle studies. 
Both AcK and PrK are commonly used to investigate the 
effect of lysine post-translational modifications (i.e., lysine 
acetylation and propionylation, respectively) in bacteria 
and eukaryotic cells (Drazic et al. 2016; Ju and He 2017; 
Lin et al. 2012). TAcK is a stable analog mimicking lysine 
acetylation, but the carbonyl functionality is replaced with a 
thiocarbonyl group thereby preventing enzymatic hydrolysis 
(Venkat et al. 2017; Xiong et al. 2016). Due to the struc-
tural similarity, AcK and PrK can be incorporated by both 
AcKRS and PrKRS, and TAcK is likely to be accepted by 
these PylRS variants as well. On the other hand, PCC has 
a distinct structure when compared to the lysine analogs. 
PCC has a photolabile protecting group on the cysteine side 
chain, useful in light-controlled protein activation of active 
cysteines (Nguyen et al. 2014).
Overall, we found that R19H/H29R mutations have negli-
gible benefits to MbPylRS variants. In two cases (i.e., PrKRS 
and PCCRS), the N-terminal mutations greatly decreased 
the unnatural amino acid incorporation. Our results high-
light the difference between MbPylRS and MmPylRS, two 
closely related homologs, and raise concerns of using these 
homologs interchangeably in genetic code expansion.
Methods
Unnatural amino acids
BocK (Fluorochem, #078,520) and AcK (Fluorochem, 
#324,288) are commercially available. TAcK (Venkat et al. 
2017), PrK (Gattner et al. 2013) and PCC (Nguyen et al. 
2014) were synthesized following the literature procedures.
Cloning
A MbPylRS variant and the Pyl tRNA are expressed from 
a pCDF vector, in which the synthetase and the tRNA are 
under the control of constitutively active GlnS promoter and 
Ipp promoter, respectively. Four variants of MbPylRS were 
tested here, including the wild-type enzyme, MbAcKRS 
(D76G/S123G/L266M/L270I/Y271F/L274A/C313F) (Neu-
mann et al. 2009), MbPrKRS (Y271F/C313T) (Wilkins et al. 
2015) and MbPCCRS (N311Q/C313A/V366M) (Nguyen 
et al. 2014). Apart from the wild-type enzyme, the other 
variants contain mutations indicated in the brackets for rec-
ognizing the designated unnatural amino acid (Table 1).
Plasmids PylST (Neumann et al. 2010), AcKST (Neu-
mann et al. 2009) and PCCST (Nguyen et al. 2014) are kind 
gifts from Jason Chin. Plasmid PrKST was constructed by 
two rounds of PCR. Firstly, Y271F mutation was introduced 
using PylST as the template and the primers AAC TAT CTG 
CGT AAA CTG GAT CGT ATT CTG and TCC AGT TTA CGC 
AGA TAG TTA AAC AGG GTC GGG GCC AGC ATC for PCR. 
The resulting PCR product (6 kb) was directly transformed 
into E. coli Stbl3 (ThermoFisher, #C737303), and plasmids 
were extracted from cells surviving in spectinomycin (50 µg/
ml) containing media. The extracted plasmid served as the 
Fig. 2  Structures of the five unnatural amino acids used in this study
Table 1  Comparison of 
C-terminal mutations in the four 
MbPylRS variants used in this 
study
Residue no. 76 123 266 270 271 274 311 313 366
MbPylRS D S L L Y L N C V
MbAcKRS G G M I F A N F V
MbPrKRS D S L L F L N T V
MbPCCRS D S L L Y L Q A M
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template for the second round of PCR with primers AAT 
TCA CCA TGG TTA ACT TTA CCC AAA TGG GCA GCG 
GCT GCA C and AAA GTT AAC CAT GGT GAA TTC TTC 
CAG GTG to introduce mutation C313T, providing plasmid 
PrKST.
The N-terminal mutations (R19H/H29R) were introduced 
into each PylRS variant by PCR using primers TGG ATG 
AGC CAT ACC GGC ACC CTG CAT AAA ATC AAA CAT CGT 
GAA GTG AG and TGC CGG TAT GGC TCA TCC ACA GGC 
CGG TCG CGC TAA TCA GCA CATC. All PCR reactions 
were performed using PrimeStar Max DNA polymerase 
(TaKaRa, #R045A).
Plasmid pET sfGFP(150TAG) has been deposited at 
the Addgene (Plasmid #133,455) and was constructed in 
two steps. Plasmid pBAD sfGFP (Reddington et al. 2012), 
a kind gift from Dafydd Jones, was digested with restric-
tion enzyme NcoI and XhoI to excise the gene encoding 
sfGFP, which was cloned into a pET 28a vector using the 
same restriction sites to afford pET sfGFP. The mutation 
N150TAG was introduced by PCR using primers AAT ATA 
AAT TCA ACA GCC ATT AGG TGT ATA TTA CCG ATA AAC 
AG and TGG CTG TTG AAA TTA TAT TCC AGT TTA TGA 
CC.
Determining unnatural amino acid incorporation 
efficiency
The workflow is illustrated in Fig. 3. Specifically, chemi-
cally competent E. coli BL21(DE3) cells were transformed 
with the reporter plasmid, pET sfGFP(150TAG), and the 
appropriate PylRS plasmid. The transformation was con-
ducted by incubation with plasmids on ice for 10 min, heat 
shock at 42 °C for 45 s, incubation on ice for 2 min, and 
recovery in fresh LB media at 37 °C for 1 h with constant 
agitation. Cells were added into fresh LB media (10 ml) 
containing kanamycin (50 µg/ml, selection marker of the 
reporter plasmid) and spectinomycin (50 µg/ml, selec-
tion marker of the PylRS plasmid). Cells were cultured at 
37 °C overnight with constant agitation.
The overnight culture was diluted into fresh LB 
media (25  ml) containing kanamycin (50  µg/ml) and 
spectinomycin (50  µg/ml) to reach  OD600 = 0.1. This 
culture was incubated at 37  °C with constant agi-
tation until  OD600 = 0.6–0.8, and isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to reach the final 
concentration of 1 mM. The culture was split into 50-ml 
falcon tubes (5-ml culture per tube), and unnatural amino 
acid was added, if required, to reach the final concentration 
of 5 mM (except for BocK, final concentration = 1 mM). 
Cultures were incubated at 25 °C or 37 °C for 18 h with 
constant agitation for protein production.
After incubation,  OD600 of the cultures were recorded, 
and samples (1 ml) were taken from each culture. The 
samples were centrifuged at 20  °C and 21,130 × g for 
5 min. Supernatants were removed, and the pellets were 
resuspended in PBS. The samples were centrifuged 
again at 20 °C and 21,130 × g for 5 min. Supernatants 
were removed, and the pellets were resuspended in PBS 
to  OD600 = 1.0. The resuspension (200  µl) was placed 
into a 96-well plate, and the fluorescence was meas-
ured by a BMG Labtech FLUOstar OPTIMA microplate 
reader (excitation wavelength = 485 nm, emission wave-
length = 520 nm, 20 flashes per well, 0.2 position delay, 
gain = 1000, shaking for 30  s before plate reading at 
25 °C). Three biological repeats of each expression con-
dition and two technical repeats of each fluorescent meas-
urement were performed.
Fig. 3  Experimental workflow. Cells were incubated at 37  °C unless otherwise stated. Biological replicates were prepared from independent 
transformations. Technical replicates were prepared from the IPTG-induced cultures. See text description for details
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Results
Our aim is to examine if the beneficial effect of R19H/
H29R mutations found in the study of MmPylRS (Sharma 
et al. 2018) is transferable to MbPylRS. To investigate, 
we employed a fluorescence-based assay. Synthetase vari-
ants containing additional R19H/H29R mutations in the 
N-terminal domain of PylRS are denoted with an asterisk 
(*). For example, MbPylRS refers to the synthetase with 
Fig. 4  Unnatural amino acid incorporation efficiency by different 
MbPylRS variants. Transformed E. coli BL21(DE3) were normal-
ized to  OD600 = 1.0 before fluorescence measurement. Means and 
standard deviations are plotted, and their values are listed in Table 2. 
The asterisk (*) denotes synthetase variants contain additional R19H/
H29R mutations in the N-terminal domain. UAA: unnatural amino 
acid. Fluorescence analysis of a wild-type MbPylRS, b AcKRS, c 
PrKRS and d PCCRS
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the wild-type sequence, whereas MbPylRS* refers to the 
synthetase containing R19H/H29R mutations with respect 
to the wild-type sequence. In our assay, production of full-
length and functional sfGFP only takes place when the 
amber codon is successfully suppressed (i.e., decoded by the 
Pyl tRNA for unnatural amino acid incorporation). As the 
fluorescence intensity is proportional to the quantity of full-
length, functional sfGFP, it provides a quantitative measure 
with regards to the unnatural amino acid incorporation.
In all MbPylRS synthetase variants tested, R19H/H29R 
mutations did not improve the incorporation efficiency 
over the wild-type sequence for any of the five amino acids 
(Fig. 4). At 25 °C, R19H/H29R mutations seemed to be 
beneficial to PylRS (Fig. 4a) and AcKRS (Fig. 4b) at the 
first glance. However, upon statistical analysis, the mean 
normalized fluorescence values for BocK incorporation 
by MbPylRS at 25 °C (Table 2, entry 2), as well as for 
AcK, TAcK or PrK incorporation by MbAcKRS at 25 °C 
(Table 2, entries 4, 6, 8) are not statistically significant 
different (P > 0.1) between the variants with the wild-type 
and the N-terminal mutations. Intriguingly, the N-termi-
nal mutations greatly diminished the activity of PrKRS 
(Fig. 4c) and PCCRS (Fig. 4d). On the other hand, it is 
noteworthy that PrK is a better substrate than AcK in both 
PrKRS and AcKRS.
Discussion
Here, we investigated the effect of R19H/H29R mutations 
in MbPylRS variants for unnatural amino acid incorpora-
tion. We tested four MbPylRS variants (i.e., wild-type, 
AcKRS, PrKRS, PCCRS), five unnatural amino acids 
(BocK, AcK, TAcK, PrK, PCC), and two culture tem-
peratures (37 °C or 25 °C). While for three MmPylRS 
variants it was found that R19H/H29R mutations together 
with T122S mutation (corresponding residue of MmPyl 
Thr122 is already Ser, Fig. 1) improved unnatural amino 
acid incorporation (12), MbPylRS variants containing 
R19H/H29R mutations do not show any beneficial effect.
There is no correlation between point mutations in 
the C-terminus of the PylRS variants and the effect of 
N-terminal mutations on incorporation efficiency. This is 
evident by the lack of activity observed with MbPrKRS* 
and MbPCCRS*, negligible difference was observed 
between MbPylRS and MbPylRS*, as well as MbAcKRS 
and MbAcKRS*. It is likely that the two closely related 
homologs, while often used interchangeably in genetic 
code expansion (Brown et al. 2018; Chin 2017; Nodling 
et  al. 2019), are different in their underlying molecu-
lar mechanisms for functional regulation and catalytic 
activity. Indeed, there are 35 extra amino acid residues 
in the N-terminal domain of MmPylRS, and this differ-
ence accounts for the difference in the length of the two 
homologs (MmPylRS: 454 amino acids; MbPylRS: 419 
amino acids). On the other hand, wild-type MmPylRS 
and MbPylRS have been reported with different substrate 
scope. For example, while Nε-L-thiaprolyl-L-lysine and 
Nε-L-cysteinyl-L-lysine are barely recognized by wild-
type MmPylRS as a substrate, they can be readily incor-
porated into a protein using wild-type MbPylRS (Nguyen 
et al. 2011). To improve unnatural amino acid incorpora-
tion efficiency, it would be necessary to perform detailed 
Table 2  P values of paired 
t tests comparing the effect 
of R19H/H29R in MbPylRS 
variants
P values < 0.05 are shown in bold. Original fluorescence data are in S2 data
Entry Temperature UAA Normalized fluorescence (mean ± standard deviation) P value
Wild-type N-terminal R19H/H29R
1 37 °C BocK MbPylRS (7443 ± 2010) MbPylRS* (5081 ± 764) 1.0 × 10–2
2 25 °C BocK MbPylRS (5023 ± 1895) MbPylRS* (5919 ± 3900) 5.4 × 10–1
3 37 °C AcK MbAcKRS (1059 ± 459) MbAcKRS* (443 ± 105) 2.9 × 10–3
4 25 °C AcK MbAcKRS (912 ± 403) MbAcKRS* (1013 ± 255) 6.1 × 10–1
5 37 °C TAcK MbAcKRS (360 ± 165) MbAcKRS* (157 ± 51) 6.1 × 10–3
6 25 °C TAcK MbAcKRS (339 ± 129) MbAcKRS* (390 ± 83) 3.9 × 10–1
7 37 °C PrK MbAcKRS (3104 ± 1147) MbAcKRS* (2851 ± 1375) 7.4 × 10–1
8 25 °C PrK MbAcKRS (4621 ± 1590) MbAcKRS* (5972 ± 1610) 1.4 × 10–1
9 37 °C AcK MbPrKRS (384 ± 81) MbPrKRS* (85 ± 38) 8.3 × 10–7
10 25 °C AcK MbPrKRS (77 ± 25) MbPrKRS* (42 ± 13) 1.3 × 10–2
11 37 °C PrK MbPrKRS (4067 ± 853) MbPrKRS* (203 ± 114) 1.2 × 10–7
12 25 °C PrK MbPrKRS (2039 ± 1556) MbPrKRS* (135 ± 88) 1.4 × 10–2
13 37 °C PCC MbPCCRS (1828 ± 795) MbPCCRS* (21 ± 8) 1.2 × 10–6
14 25 °C PCC MbPCCRS (494 ± 229) MbPCCRS* (60 ± 26) 1.0 × 10–5
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investigation of each homolog independently and caution 
should be taken when transferring mutations between 
MmPylRS and MbPylRS.
Limitations
We have only tested the transferability of one set of N-ter-
minal mutations between MmPylRS and MbPylRS.
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